# IBBQ holdings: 255 positions

> IBBQ holdings as of Oct 13, 2026: GILD 8.51%, AMGN 8.09% and VRTX 7.51% and 252 more. See every weight, the cash row and the source, or download the CSV.

Data as of Oct 13, 2026. Rebuilt every trading night.

IBBQ held 255 positions as of Oct 13, 2026. Gilead Sciences Inc is the largest at 8.51%; the top 10 are 47.1% of the fund.

Source: Invesco (https://dng-api.invesco.com/cache/v1/accounts/en_US/shareclasses/46138G599/holdings/fund?idType=cusip&productType=ETF).

| # | Holding | Ticker | Weight |
| --- | --- | --- | --- |
| 1 | Gilead Sciences Inc | GILD | 8.51% |
| 2 | Amgen Inc | AMGN | 8.09% |
| 3 | Vertex Pharmaceuticals Inc | VRTX | 7.51% |
| 4 | Moderna Inc | MRNA | 5.95% |
| 5 | Regeneron Pharmaceuticals Inc | REGN | 5.25% |
| 6 | Illumina Inc | ILMN | 2.82% |
| 7 | Revolution Medicines Inc | RVMD | 2.78% |
| 8 | Biogen Inc | BIIB | 2.33% |
| 9 | Alnylam Pharmaceuticals Inc | ALNY | 2.06% |
| 10 | Royalty Pharma PLC | RPRX | 1.74% |
| 11 | Roivant Sciences Ltd | ROIV | 1.66% |
| 12 | United Therapeutics Corp | UTHR | 1.61% |
| 13 | Incyte Corp | INCY | 1.52% |
| 14 | Argenx SE | ARGX | 1.50% |
| 15 | Guardant Health Inc | GH | 1.50% |
| 16 | Insmed Inc | INSM | 1.46% |
| 17 | Viatris Inc | VTRS | 1.36% |
| 18 | Medpace Holdings Inc | MEDP | 1.17% |
| 19 | Exelixis Inc | EXEL | 1.02% |
| 20 | Ascendis Pharma A/S | ASND | 0.95% |
| 21 | Neurocrine Biosciences Inc | NBIX | 0.95% |
| 22 | Jazz Pharmaceuticals PLC | JAZZ | 0.94% |
| 23 | Bridgebio Pharma Inc | BBIO | 0.87% |
| 24 | BeOne Medicines Ltd | ONC | 0.86% |
| 25 | Halozyme Therapeutics Inc | HALO | 0.86% |
| | Cash & Equivalents | | 0.01% |
| | Cash and other net assets | | −0.002% |

The largest 25 of 255 positions are shown. All of them: https://etfiq.com/funds/ibbq/holdings/ibbq-holdings.csv (CSV) or https://etfiq.com/data/books/ibbq.json (JSON).

Fund page: https://etfiq.com/funds/ibbq

Cite: ETFIQ, Holdings of IBBQ, data as of Oct 13, 2026. https://etfiq.com/funds/ibbq/holdings/